Posted by: Clear Vision Cataract & LASIK Center

Maybe you’ve wanted to ditch glasses for years, and you have already done all the research, only to go to your consultation, or almost went, and then someone mentioned your prescription might be too high for LASIK. And you filed it under ‘guess that’s not for me’ and moved on.

But there may be other options for you.

For patients with high prescriptions (those that tend to fall outside LASIK’s range), there’s a procedure called EVO ICL, and we have seen some of the best vision correction outcomes today.

What Is EVO ICL?

ICL stands for Implantable Collamer Lens. EVO is the current generation of that technology. It’s a small, flexible lens made from a biocompatible material containing a small amount of collagen, placed inside the eye just in front of the natural lens.

Unlike LASIK, which permanently reshapes corneal tissue, the ICL doesn’t alter your cornea at all. It sits inside your eye and corrects your vision the way glasses or contacts do — just without anything you can see, feel, or take out. The lens is designed to stay in place indefinitely, but if your prescription changes dramatically or you want it removed for any reason, it can be.

Who Is It For?

EVO ICL was designed specifically for patients who fall outside the range of laser correction. That typically means:

  • Prescriptions that are too high for LASIK or SMILE to safely address
  • Patients with corneas that are too thin for a laser procedure
  • Significant dry eye that makes laser surgery a less advisable option
  • Patients who are generally between ages 21 and roughly 45, before the natural lens starts changing in ways that make a different procedure more appropriate

Patients in this group often spend years assuming nothing can be done about their vision beyond glasses and contacts and we want to assure you, that’s not always the case.

What Are the Outcomes Like?

Consistently strong. In the FDA clinical trial for EVO ICL, 75.9% of patients achieved 20/20 vision or better at six months. In a large U.S. single-center analysis published in Clinical Ophthalmology, 95.2% of patients who were correctable to 20/20 preoperatively achieved 20/20 or better uncorrected vision at one month, with zero major adverse events reported.

Because the procedure doesn’t remove corneal tissue, there’s no risk of the corneal thinning complications that can occasionally occur with laser approaches in high-prescription patients.

Recovery is also remarkably fast. Most patients notice dramatically improved vision within the first day or two. The procedure is outpatient, takes roughly 20 to 30 minutes, and is performed with a local anesthetic. Which means there are no needles and no general anesthesia.

What About the Natural Lens?

The ICL works alongside your natural lens, not instead of it. That’s actually one of its strengths: unlike refractive lens exchange (which replaces the natural lens), EVO ICL preserves your ability to accommodate, meaning younger patients who haven’t yet lost their near focusing ability keep it.

For patients in their 40s and beyond whose near vision is already starting to shift, that trade-off looks different, and a different procedure might serve them better. A thorough consultation will map out exactly where you fall.

The Conversation Worth Having

If you’ve been turned down for LASIK or assumed you weren’t a candidate, the EVO ICL evaluation is a separate assessment because the criteria and corneal requirements differ.

We’ve had patients come into Clear Vision Center convinced that nothing could help their prescription, and leave scheduled for a procedure they didn’t know was available to them. (And yes, that happens more often than you’d expect.)

If you’re ready to find out if you qualify, you can start with a consultation at our Rochester or Bloomfield Hills locations. Call us at (248) 215-0326 or request an appointment at clearvisioncenter.com.